ALKS
Alkermes (ALKS)
NASDAQ
$46.00+$0.02 (+0.05%)
Price as of Sep 11, 2026 7:30 PM EDT
  • $7.6B
    Market Cap
  • 70.45%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 41
Valuation
ALKS
vs History
vs S&P 500
Profitability
-0
Growth
-1
Low Earnings Volatility
0

Momentum Score

Score: 54
Valuation
ALKS
vs History
vs S&P 500
3-Month Momentum
13.52%
12-Month Momentum
81.45%
3-Month Risk Adjusted Momentum
84.91%
12-Month Risk Adjusted Momentum
205.77%

True Yield

N/A
Valuation
ALKS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
1.04%
Net Debt Paydown Yield
0.14%

Financial Health Score

Score: 0
Valuation
ALKS
vs History
vs S&P 500
Ohlson's O-Score
6